GZMB and neoplasm: It is secreted by tumor cells and acts via the E-type prostanoid receptor 4 (EP4) on NK cells to inhibit their maturation, reduce the expression of cytotoxic molecules such as granzyme B and perforin, and limit their ability to lyse tumor targets [16].